Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Relative survival rates after alternative therapies for uveal melanoma.

Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Howard S, Fante RG, Albert DM.

Ophthalmology. 1990 Jun;97(6):769-77.

PMID:
2374681
2.

[Preoperative irradiation before enucleation in malignant melanoma of the uvea. Review of the literature and initial personal experiences].

Bornfeld N, Huser U, Sauerwein W, Wessing A, Sack H.

Klin Monbl Augenheilkd. 1989 Apr;194(4):252-60. Review. German.

PMID:
2657203
3.

Eye retention after proton beam radiotherapy for uveal melanoma.

Egger E, Zografos L, Schalenbourg A, Beati D, Böhringer T, Chamot L, Goitein G.

Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):867-80. Review.

PMID:
12605964
4.

Episcleral plaque radiotherapy for uveal melanoma.

Giblin ME, Shields JA, Augsburger JJ, Brady LW.

Aust N Z J Ophthalmol. 1989 May;17(2):153-6. Review.

PMID:
2667581
5.

Uveal melanoma: therapeutic consequences of doubling times and irradiation results; a review.

Manschot WA, van Strik R.

Int Ophthalmol. 1992 Mar;16(2):91-9. Review.

PMID:
1587700
6.

An evaluation of enucleation in the management of uveal melanomas.

Zimmerman LE, McLean IW.

Am J Ophthalmol. 1979 Jun;87(6):741-60. Review.

PMID:
377973
7.

The Zimmerman-McLean-Foster hypothesis: 25 years later.

Singh AD, Rennie IG, Kivela T, Seregard S, Grossniklaus H.

Br J Ophthalmol. 2004 Jul;88(7):962-7. Review.

Supplemental Content

Support Center